Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Resch

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Zeitschrift Fur Medizinische Physik|March 21, 2026
State-of-the-art and future developments in dosimetry for sstr- and PSMA-targeting radioligand therapiesSandra Resch, Astrid Delker
Cancers|July 29, 2025
Feasibility of Automated Image-Based Red Bone Marrow Dosimetry for [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy of Metastatic Castration-Resistant Prostate CancerMikhail Rumiantcev, Sandra Resch, Grigory Liubchenko, et al.
EJNMMI Physics|September 11, 2023
Estimation of relative biological effectiveness of <sup>225</sup>Ac compared to <sup>177</sup>Lu during [<sup>225</sup>Ac]Ac-PSMA and [<sup>177</sup>Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRASMikhail Rumiantcev, Wei Bo Li, Simon Lindner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2024
Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-I&T TherapySandra Resch, Sibylle I Ziegler, Gabriel Sheikh, et al.
Scientific Reports|October 27, 2024
Grating-based phase-contrast computed tomography for breast tissue at an inverse compton sourceDaniel Berthe, Lisa Heck, Sandra Resch, et al.
Medical Physics|January 3, 2025
Grating-based x-ray dark-field mammography: Assessing complementary imaging information in simple cystic lesions and typical fibroadenomaKarin Hellerhoff, Wolfgang Gottwald, Kirsten Taphorn, et al.
EJNMMI Physics|October 2, 2025
Comparison of scatter and partial volume correction techniques for quantitative SPECT imaging of <sup>225</sup>AcGrigory Liubchenko, Guido Böning, Mikhail Rumiantcev, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 21, 2024
Image-based dosimetry for [<sup>225</sup>Ac]Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokineticsGrigory Liubchenko, Guido Böning, Mathias Zacherl, et al.
EJNMMI Physics|February 9, 2023
Investigation of image-based lesion and kidney dosimetry protocols for <sup>177</sup>Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisitionSandra Resch, Sarah Takayama Fouladgar, Mathias Zacherl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 11, 2023
Biodistribution and dosimetry for combined [<sup>177</sup>Lu]Lu-PSMA-I&T/[<sup>225</sup>Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imagingAstrid Delker, Mirjam Schleske, Grigory Liubchenko, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Zeitschrift Fur Medizinische Physik|March 21, 2026
State-of-the-art and future developments in dosimetry for sstr- and PSMA-targeting radioligand therapiesSandra Resch, Astrid Delker
Cancers|July 29, 2025
Feasibility of Automated Image-Based Red Bone Marrow Dosimetry for [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy of Metastatic Castration-Resistant Prostate CancerMikhail Rumiantcev, Sandra Resch, Grigory Liubchenko, et al.
EJNMMI Physics|September 11, 2023
Estimation of relative biological effectiveness of <sup>225</sup>Ac compared to <sup>177</sup>Lu during [<sup>225</sup>Ac]Ac-PSMA and [<sup>177</sup>Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRASMikhail Rumiantcev, Wei Bo Li, Simon Lindner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2024
Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-I&T TherapySandra Resch, Sibylle I Ziegler, Gabriel Sheikh, et al.
Scientific Reports|October 27, 2024
Grating-based phase-contrast computed tomography for breast tissue at an inverse compton sourceDaniel Berthe, Lisa Heck, Sandra Resch, et al.
Medical Physics|January 3, 2025
Grating-based x-ray dark-field mammography: Assessing complementary imaging information in simple cystic lesions and typical fibroadenomaKarin Hellerhoff, Wolfgang Gottwald, Kirsten Taphorn, et al.
EJNMMI Physics|October 2, 2025
Comparison of scatter and partial volume correction techniques for quantitative SPECT imaging of <sup>225</sup>AcGrigory Liubchenko, Guido Böning, Mikhail Rumiantcev, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 21, 2024
Image-based dosimetry for [<sup>225</sup>Ac]Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokineticsGrigory Liubchenko, Guido Böning, Mathias Zacherl, et al.
EJNMMI Physics|February 9, 2023
Investigation of image-based lesion and kidney dosimetry protocols for <sup>177</sup>Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisitionSandra Resch, Sarah Takayama Fouladgar, Mathias Zacherl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 11, 2023
Biodistribution and dosimetry for combined [<sup>177</sup>Lu]Lu-PSMA-I&T/[<sup>225</sup>Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imagingAstrid Delker, Mirjam Schleske, Grigory Liubchenko, et al.
Pageof 2